The VIP/VPAC1R Pathway Regulates Energy and Glucose Homeostasis by Modulating GLP-1, Glucagon, Leptin and PYY Levels in Mice
Open Access
Abstract
Vasoactive Intestinal Peptide binds with high affinity to VPAC1R and VPAC2R, thus regulating key physiologic functions. Previously, we documented in VIP−/− mice a leaner body phenotype and altered metabolic hormones. Past reports described in VPAC2−/− mice impaired circadian rhythm, reduced food intake, and altered metabolism. To better define the effects of VPAC1R on body phenotype, energy/glucose homeostasis, and metabolism, we conducted a 12-week study in a VPAC1R null model. Our results reveal that VPAC1−/− mice experienced significant metabolic alterations during the dark cycle with greater numbers of feeding bouts (p = 0.009), lower Total Energy Expenditure (p = 0.025), VO2 (p = 0.029), and VCO2 (p = 0.016); as well as during the light cycle with lower Total Energy Expenditure (p = 0.04), VO2 (p = 0.044), and VCO2 (p = 0.029). Furthermore, VPAC1−/− mice had significantly higher levels of GLP-1 and PYY during fasting, and higher levels of GLP-1, glucagon leptin and PYY during postprandial conditions. In addition, VPAC1−/− mice had lower levels of glucose at 60′ and 120′, as assessed by insulin tolerance test. In conclusion, this study supports a key role for VPAC1R in the regulation of body glucose/energy homeostasis and metabolism.Keywords
This publication has 65 references indexed in Scilit:
- Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1British Journal of Pharmacology, 2012
- The VPAC1 receptor: structure and function of a class B GPCR prototypeFrontiers in Endocrinology, 2012
- A guide to analysis of mouse energy metabolismNature Methods, 2011
- VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studiesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2011
- Peptides and Their Potential Role in the Treatment of Diabetes and ObesityThe Review of Diabetic Studies, 2011
- Effect of VPAC1 Blockade on Adipose Tissue Formation and Composition in Mouse Models of Nutritionally Induced ObesityJournal of Obesity, 2010
- Vasoactive Intestinal Peptide–Null Mice Demonstrate Enhanced Sweet Taste Preference, Dysglycemia, and Reduced Taste Bud Leptin Receptor ExpressionDiabetes, 2010
- Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated withCitrobacter rodentium-induced colitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- The Meter of MetabolismCell, 2008
- Coordination of circadian timing in mammalsNature, 2002